# EyeBrain

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/eyebrain

- Industry: Medical Devices & Equipment
- Headquarters: Ivry-sur-Seine, France
- Website: www.eye-brain.com
- Total disclosed funding: $4.3M
- Latest round: Series B (Oct 22, 2012)
- Investors on record: 4

## About

EyeBrain develops advanced eye-tracking solutions that facilitate the diagnosis and monitoring of neuro-visual dysfunctions and neurological disorders, improving clinical assessments and patient care.Founded in 2008, EyeBrain operates out of Ivry-sur-Seine, France, specializing in medical technologies. The company has undergone strategic business developments, including a significant funding round in November 2015, where they raised EUR 1.28 million from various investors, including Fonds régional de co-investissement Île-de-France and ANAXAGO, to enhance their product offerings. EyeBrain has completed a total of 4 deals, with the latest funding round driving their current valuation to EUR 7.322 mn.EyeBrain offers specialized products such as EyeBrain® NEO software and the Weetsy eye tracker, which are critical for the diagnosis of conditions like Alzheimer's and ADHD. These products allow healthcare professionals to accurately manage patient data and analyze eye movement in real-time, thereby supporting hospitals and research institutions across Europe.Revenue is generated through direct sales of their devices and software subscriptions. EyeBrain's business model is structured around B2B transactions with healthcare providers, ensuring customized solutions and comprehensive support for medical professionals.With the recent funding of EUR 1.28 million, EyeBrain aims to enhance its product line and expand its market reach. The company is focusing on the development of new features for their EyeBrain® NEO software and Weetsy eye tracker, with plans to penetrate additional European markets by 2015 to cater to a growing client base in the healthcare sector.

## Funding rounds

- Series B, Oct 22, 2012, $4.3M — Sudinnova, Credit Mutuel Equity, Karista, OCTALFA

## Investors

- Sudinnova (https://capitalatlas.ai/funds/sudinnova) — Series B
- Credit Mutuel Equity (https://capitalatlas.ai/funds/credit-mutuel-equity) — Series B
- Karista (https://capitalatlas.ai/funds/karista) — Series B
- OCTALFA — Series B